A PHASE III, PROSPECTIVE OPEN-LABEL, MULTI-CENTER SINGLE ARM STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS (PK) PROFILE OF INTRAVENOUS HUMAN NORMAL IMMUNOGLOBULIN (IgG) IN PRIMARY IMMUNODEFICIENCY DISEASE (PID) PATIENTS
داعم الدراسة
SK Plasma Co.
دواء الدراسة
LIV-GAMMA SN Injection
رقم بروتوكول الدراسة
SKP-LIV_PID_III_2023
حالة الدراسة
Ongoing
موقع الدراسة
King Abdulaziz University Hospital (Jeddah) ,King Fahad Hospital (Jeddah), Al-Aziziyah Maternity and Children's Hospital
مرحلة الدراسة
3
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.